DEUTSCHE BANK AG\ - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 47 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q1 2022$81,000
-49.7%
12,366
-10.5%
0.00%
Q4 2021$161,000
-34.0%
13,824
+5.5%
0.00%
Q3 2021$244,000
-14.7%
13,108
-3.1%
0.00%
Q2 2021$286,000
+140.3%
13,522
+131.1%
0.00%
Q1 2021$119,000
-26.5%
5,852
-3.9%
0.00%
Q4 2020$162,0006,0890.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 1,391,190$29,493,00022.62%
Octagon Capital Advisors LP 320,440$6,793,0001.41%
Artal Group S.A. 1,040,882$22,067,0000.45%
Alphabet Inc. 640,882$13,587,0000.28%
Nantahala Capital Management 432,072$9,160,0000.26%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 500,000$10,600,0000.22%
TimesSquare Capital Management, LLC 683,400$14,488,0000.12%
Perceptive Advisors 640,880$13,586,0000.09%
Virtus ETF Advisers LLC 8,697$184,0000.08%
Granite Point Capital Management, L.P. 50,000$1,060,0000.04%
View complete list of TAYSHA GENE THERAPIES INC shareholders